Yellow fever vaccines and international travelers
@article{Barnett2008YellowFV, title={Yellow fever vaccines and international travelers}, author={Elizabeth D. Barnett and Annelies Wilder-Smith and Mary E. Wilson}, journal={Expert Review of Vaccines}, year={2008}, volume={7}, pages={579 - 587} }
The growth of air travel has diminished the barriers to the spread of yellow fever, posing a threat to regions that have not previously been reached by the disease but are considered receptive, including the Middle East, coastal East Africa, the Indian subcontinent, Asia and Australia. For many decades, vaccination against yellow fever has been required for travelers entering many countries with receptive mosquito vectors in order to prevent the importation of yellow fever virus from a country…
25 Citations
Review of the risks and benefits of yellow fever vaccination including some new analyses
- MedicineExpert review of vaccines
- 2012
Multiple factors should be considered in making decisions about YF vaccination, including specific destination, season of the year, local evidence for YF transmission, likelihood of exposure to vector mosquitoes and individual risk factors for YEL-AVD, with the goal of increasing vaccine coverage for travel to high-risk areas and reducing unnecessary vaccination.
Evaluation of Safety Profile of Yellow Fever Vaccine in Healthy IndianTravellers: A Prospective Observational Study
- Medicine
- 2015
It is fair to conclude that Yellow fever vaccine is safe and well tolerated in healthy Indian travelers on a limited number of subjects.
Travel patterns and health risks for patients infected with HIV.
- MedicineTravel medicine and infectious disease
- 2009
Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic
- MedicineJournal of Korean medical science
- 2019
Travelers should be aware of required vaccination and malaria prophylaxis before visiting South and Central America and Asia and plans to enhance compliance of the elderly and business travelers should be contrived.
Evaluating a Sick Child after Travel to Developing Countries
- MedicineThe Journal of the American Board of Family Medicine
- 2010
With a focus first on ruling out life-threatening disease and subsequently on an informed and efficient path to diagnosis and treatment, clinicians may confidently provide care for this challenging group of patients.
Trends in importation of communicable diseases into Singapore.
- MedicineAnnals of the Academy of Medicine, Singapore
- 2010
It is underlines that diseases such as malaria, viral hepatitis and enteric fever occur in Singapore mainly because of importation and the proportion of imported diseases in relation to overall passenger traffic has decreased over the past 10 years.
Japanese encephalitis: is there a need for a novel vaccine?
- MedicineExpert review of vaccines
- 2009
Although rigorous surveillance is lacking in most endemic countries, transmission intensity is probably increasing in Bangladesh, Cambodia, Indonesia, Laos, Myanmar and Pakistan owing to growing human populations, and intensified pig-rearing.
Yellow fever in a Brazilian family returning from vacation in an endemic area: relevant clinical features and epidemiological issues.
- MedicineJournal of travel medicine
- 2009
Three cases of yellow fever are reported in a family traveling from the city of Sao Paulo, Brazil to an endemic area, acquiring the disease and presenting mild-to-moderate symptoms, which alerts to the threat of introduction and spread of YF in the urban cycle, when infected travelers return to non-endemic areas.
References
SHOWING 1-10 OF 62 REFERENCES
Yellow fever immunizations: Indications and risks
- MedicineCurrent infectious disease reports
- 2004
The adverse events associated with the yellow fever vaccine are described, postulated reasons for the recent recognition of these events are reviewed, and key research questions that need to be addressed in trying to understand their origin and risk factors are discussed.
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
- MedicineMMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
- 2010
Administration of YF vaccine is recommended for persons aged aged >or=9 months who are traveling to or living in areas of South America and Africa in which a risk exists for YFV transmission.
The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice.
- MedicineThe American journal of tropical medicine and hygiene
- 2008
The extended spectrum of diseases and events under IHR (2005) that may cause a public health emergency of international concern necessitated a revision of the existing “ International Certificate of Vaccination or Revaccination Against Yellow Fever” to the “International Certificate ofvaccination or Prophylaxis” (ICVP).
First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations.
- MedicineThe American journal of tropical medicine and hygiene
- 1998
This was the first documented outbreak of YF in Kenya, a classic example of a sylvatic transmission cycle, and surveillance in rural and urban areas outside the vaccination area should be intensified.
Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.
- MedicineVaccine
- 2005
Congenital Arboviral Infections: Something New, Something Old
- MedicinePediatrics
- 2006
In 1999, West Nile virus (WNV), a member of the JEV antigenic complex of flaviviruses (family Flaviviridae) discovered in 1937, was introduced into the Western hemisphere, paralleling in some respects the emergence of JEV in northern India.
Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future.
- MedicineThe American journal of tropical medicine and hygiene
- 1991
Although discovery of the jungle cycle of yellow fever transmission in 1935 dispelled hopes of ever eradicating the disease, widescale use of vaccines in the 1940s and systematic efforts to subdue Ae.
Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
- BiologyVaccine
- 2006
Advanced age a risk factor for illness temporally associated with yellow fever vaccination.
- MedicineEmerging infectious diseases
- 2001
It is found that the rate of reported adverse events among elderly vaccinees was higher than among vaccinees 25 to 44 years of age, and two additional deaths among elderly YF vaccinees are found, suggesting enhanced surveillance is needed.